RSNA 2014 

Abstract Archives of the RSNA, 2014


SPSI22D

FDG-PET for Cancer Staging and Monitoring

Special Courses

Presented on December 1, 2014
Presented as part of SPSI22: Special Interest Session: Optimizing Quantitative Imaging Biomarkers for Practice: QIBA Examples from CT, MR, PET and US

Participants

Richard L. Wahl MD, Presenter: Patent holder, Naviscan, Inc Patent holder, GlaxoSmithKline plc Patent holder, Spectrum Pharmaceuticals, Inc Research Consultant, GlaxoSmithKline plc Research Consultant, Nihon Medi-Physics Co, Ltd Research support, General Electric Company Research support, Molecular Insight Pharmaceuticals, Inc Research support, Cell Point LLC

LEARNING OBJECTIVES

View learning objectives under main course title.

Cite This Abstract

Wahl, R, FDG-PET for Cancer Staging and Monitoring.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14002939.html